Therapeutic targeting of leukemic stem cells in acute myeloid leukemia – the biological background for possible strategies
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Therapeutic targeting of leukemic stem cells in acute myeloid leukemia – the biological background for possible strategies
Authors
Keywords
-
Journal
Expert Opinion on Drug Discovery
Volume 12, Issue 10, Pages 1053-1065
Publisher
Informa UK Limited
Online
2017-07-27
DOI
10.1080/17460441.2017.1356818
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mesenchymal Stem Cells Support Survival and Proliferation of Primary Human Acute Myeloid Leukemia Cells through Heterogeneous Molecular Mechanisms
- (2017) Annette K. Brenner et al. Frontiers in Immunology
- Therapeutically targeting SELF-reinforcing leukemic niches in acute myeloid leukemia: A worthy endeavor?
- (2016) Paolo Bernasconi et al. AMERICAN JOURNAL OF HEMATOLOGY
- Reliable FASP-based procedures for optimal quantitative proteomic and phosphoproteomic analysis on samples from acute myeloid leukemia patients
- (2016) Maria Hernandez-Valladares et al. BIOLOGICAL PROCEDURES ONLINE
- DOT1L as a therapeutic target for the treatment of DNMT3A -mutant acute myeloid leukemia
- (2016) Rachel E. Rau et al. BLOOD
- Frequency and Dynamics of Leukemia-Initiating Cells during Short-term Ex Vivo Culture Informs Outcomes in Acute Myeloid Leukemia Patients
- (2016) Emmanuel Griessinger et al. CANCER RESEARCH
- NOX-driven ROS formation in cell transformation of FLT3-ITD-positive AML
- (2016) Ashok Kumar Jayavelu et al. EXPERIMENTAL HEMATOLOGY
- Microenvironmental oxygen partial pressure in acute myeloid leukemia: Is there really a role for hypoxia?
- (2016) Christina T. Rieger et al. EXPERIMENTAL HEMATOLOGY
- Oxidative stress and hypoxia in normal and leukemic stem cells
- (2016) Ugo Testa et al. EXPERIMENTAL HEMATOLOGY
- Inhibitors of LSD1 as a potential therapy for acute myeloid leukemia
- (2016) Amanda Przespolewski et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Functionally identifiable apoptosis-insensitive subpopulations determine chemoresistance in acute myeloid leukemia
- (2016) Patrick D. Bhola et al. JOURNAL OF CLINICAL INVESTIGATION
- MLL1 and DOT1L cooperate with meningioma-1 to induce acute myeloid leukemia
- (2016) Simone S. Riedel et al. JOURNAL OF CLINICAL INVESTIGATION
- Pharmacological inhibition of LSD1 for the treatment of MLL-rearranged leukemia
- (2016) Zizhen Feng et al. Journal of Hematology & Oncology
- Freezing effects on the acute myeloid leukemia cell proteome and phosphoproteome revealed using optimal quantitative workflows
- (2016) Elise Aasebø et al. Journal of Proteomics
- The Complexity of Targeting PI3K-Akt-mTOR Signalling in Human Acute Myeloid Leukaemia: The Importance of Leukemic Cell Heterogeneity, Neighbouring Mesenchymal Stem Cells and Immunocompetent Cells
- (2016) Annette Brenner et al. MOLECULES
- Lineage-specific and single-cell chromatin accessibility charts human hematopoiesis and leukemia evolution
- (2016) M Ryan Corces et al. NATURE GENETICS
- Distinct evolution and dynamics of epigenetic and genetic heterogeneity in acute myeloid leukemia
- (2016) Sheng Li et al. NATURE MEDICINE
- Assessment of Minimal Residual Disease in Standard-Risk AML
- (2016) Adam Ivey et al. NEW ENGLAND JOURNAL OF MEDICINE
- TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes
- (2016) John S. Welch et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genomic Classification and Prognosis in Acute Myeloid Leukemia
- (2016) Elli Papaemmanuil et al. NEW ENGLAND JOURNAL OF MEDICINE
- Integrin alphavbeta3 enhances β-catenin signaling in acute myeloid leukemia harboring Fms-like tyrosine kinase-3 internal tandem duplication mutations: implications for microenvironment influence on sorafenib sensitivity
- (2016) Hai Yi et al. Oncotarget
- A Subset of Patients with Acute Myeloid Leukemia Has Leukemia Cells Characterized by Chemokine Responsiveness and Altered Expression of Transcriptional as well as Angiogenic Regulators
- (2016) Annette K. Brenner et al. Frontiers in Immunology
- Hematopoietic cell transplantation for adults with acute myeloid leukemia with minimal residual disease
- (2015) Frederick R. Appelbaum BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- Should minimal residual disease guide therapy in AML?
- (2015) Elisabeth Paietta BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- IL8-CXCR2 pathway inhibition as a therapeutic strategy against MDS and AML stem cells
- (2015) C. Schinke et al. BLOOD
- AML cells have low spare reserve capacity in their respiratory chain that renders them susceptible to oxidative metabolic stress
- (2015) S. Sriskanthadevan et al. BLOOD
- Overexpression of the shortest isoform of histone demethylase LSD1 primes hematopoietic stem cells for malignant transformation
- (2015) T. Wada et al. BLOOD
- Proteasome inhibitors induce FLT3-ITD degradation through autophagy in AML cells
- (2015) C. Larrue et al. BLOOD
- Targeting Mitochondria with Avocatin B Induces Selective Leukemia Cell Death
- (2015) E. A. Lee et al. CANCER RESEARCH
- AMPK Protects Leukemia-Initiating Cells in Myeloid Leukemias from Metabolic Stress in the Bone Marrow
- (2015) Yusuke Saito et al. Cell Stem Cell
- Leukemia-Associated Cohesin Mutants Dominantly Enforce Stem Cell Programs and Impair Human Hematopoietic Progenitor Differentiation
- (2015) Claire Mazumdar et al. Cell Stem Cell
- A Phase I/II Study of the Janus Kinase (JAK)1 and 2 Inhibitor Ruxolitinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia
- (2015) Naveen Pemmaraju et al. Clinical Lymphoma Myeloma & Leukemia
- Targeting of cell metabolism in human acute myeloid leukemia - more than targeting of isocitrate dehydrogenase mutations and PI3K/AKT/mTOR signaling?
- (2015) Michelle Hauge et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Risk factors for relapse after allogeneic transplantation in acute myeloid leukemia
- (2015) G. J. Ossenkoppele et al. HAEMATOLOGICA
- Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML): a multicentre, phase 2, randomised controlled trial
- (2015) Christoph Röllig et al. LANCET ONCOLOGY
- In vivo targeting of leukemia stem cells by directing parthenolide-loaded nanoparticles to the bone marrow niche
- (2015) H Zong et al. LEUKEMIA
- NOX4-driven ROS formation mediates PTP inactivation and cell transformation in FLT3ITD-positive AML cells
- (2015) A K Jayavelu et al. LEUKEMIA
- Hypoxia regulates proliferation of acute myeloid leukemia and sensitivity against chemotherapy
- (2015) Heidrun Drolle et al. LEUKEMIA RESEARCH
- The pretransplant systemic metabolic profile reflects a risk of acute graft versus host disease after allogeneic stem cell transplantation
- (2015) Håkon Reikvam et al. Metabolomics
- Isocitrate dehydrogenase 1 and 2 mutations induce BCL-2 dependence in acute myeloid leukemia
- (2015) Steven M Chan et al. NATURE MEDICINE
- Acute Myeloid Leukemia
- (2015) Hartmut Döhner et al. NEW ENGLAND JOURNAL OF MEDICINE
- Biology and Clinical Relevance of Acute Myeloid Leukemia Stem Cells
- (2015) Andreas Reinisch et al. SEMINARS IN HEMATOLOGY
- Long term maintenance of myeloid leukemic stem cells cultured with unrelated human mesenchymal stromal cells
- (2015) Sawa Ito et al. Stem Cell Research
- The cytokine-mediated crosstalk between primary human acute myeloid cells and mesenchymal stem cells alters the local cytokine network and the global gene expression profile of the mesenchymal cells
- (2015) Håkon Reikvam et al. Stem Cell Research
- Inhibition of pentose phosphate pathway suppresses acute myelogenous leukemia
- (2015) Yan Chen et al. TUMOR BIOLOGY
- Emerging therapeutic targets for the treatment of human acute myeloid leukemia (part 1) – gene transcription, cell cycle regulation, metabolism and intercellular communication
- (2015) Håkon Reikvam et al. Expert Review of Hematology
- Emerging therapeutic targets in human acute myeloid leukemia (part 2) – bromodomain inhibition should be considered as a possible strategy for various patient subsets
- (2015) Håkon Reikvam et al. Expert Review of Hematology
- An LSC epigenetic signature is largely mutation independent and implicates the HOXA cluster in AML pathogenesis
- (2015) Namyoung Jung et al. Nature Communications
- Expression of the potential therapeutic target CXXC5 in primary acute myeloid leukemia cells - high expression is associated with adverse prognosis as well as altered intracellular signaling and transcriptional regulation
- (2015) Øystein Bruserud et al. Oncotarget
- Targeting PDK1 with dichloroacetophenone to inhibit acute myeloid leukemia (AML) cell growth
- (2015) Lijun Qin et al. Oncotarget
- Targeting BTK for the treatment of FLT3-ITD mutated acute myeloid leukemia
- (2015) Genevra Pillinger et al. Scientific Reports
- Co-activation of AMPK and mTORC1 Induces Cytotoxicity in Acute Myeloid Leukemia
- (2015) Pierre Sujobert et al. Cell Reports
- Risk factors for relapse after allogeneic transplantation in acute myeloid leukemia
- (2015) G. J. Ossenkoppele et al. HAEMATOLOGICA
- Differences in proliferative capacity of primary human acute myelogenous leukaemia cells are associated with altered gene expression profiles and can be used for subclassification of patients
- (2015) H. Reikvam et al. CELL PROLIFERATION
- Pharmacologic targeting of the PI3K/mTOR pathway controls release of angioregulators from primary human acute myeloid leukemia cells and their neighboring stromal cells
- (2015) Håkon Reikvam et al. Oncotarget
- Sorafenib is tolerable and improves clinical outcomes in patients with FLT3-ITD acute myeloid leukemia prior to stem cell transplant and after relapse post-transplant
- (2014) Sarah L. Sammons et al. AMERICAN JOURNAL OF HEMATOLOGY
- The Bcl-2 family: structures, interactions and targets for drug discovery
- (2014) Marc Kvansakul et al. APOPTOSIS
- MRD in AML: It is time to change the definition of remission
- (2014) Gert J. Ossenkoppele et al. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- Management of persistent AML at day 14
- (2014) Elihu Estey BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- Clonal evolution of pre-leukemic hematopoietic stem cells precedes human acute myeloid leukemia
- (2014) Ravindra Majeti BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- A distinct glucose metabolism signature of acute myeloid leukemia with prognostic value
- (2014) W.-L. Chen et al. BLOOD
- Pharmacological modulation of monocytes and macrophages
- (2014) Alberto Mantovani et al. CURRENT OPINION IN PHARMACOLOGY
- Identification of a subset of patients with acute myeloid leukemia characterized by long-termin vitroproliferation and altered cell cycle regulation of the leukemic cells
- (2014) Kimberley Joanne Hatfield et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Primary acute myeloid leukemia cells with IDH1 or IDH2 mutations respond to a DOT1L inhibitor in vitro
- (2014) S M Sarkaria et al. LEUKEMIA
- Highly effective combination of LSD1 (KDM1A) antagonist and pan-histone deacetylase inhibitor against human AML cells
- (2014) W Fiskus et al. LEUKEMIA
- Therapeutic Targeting the Cell Division Cycle 25 (CDC25) Phosphatases in Human Acute Myeloid Leukemia — The Possibility to Target Several Kinases through Inhibition of the Various CDC25 Isoforms
- (2014) Annette Brenner et al. MOLECULES
- Leukemic Stem Cell Frequency: A Strong Biomarker for Clinical Outcome in Acute Myeloid Leukemia
- (2014) Monique Terwijn et al. PLoS One
- Preleukemic mutations in human acute myeloid leukemia affect epigenetic regulators and persist in remission
- (2014) M. R. Corces-Zimmerman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Performance of super-SILAC based quantitative proteomics for comparison of different acute myeloid leukemia (AML) cell lines
- (2014) Elise Aasebø et al. PROTEOMICS
- Relevance of leukemic stem cells in acute myeloid leukemia: heterogeneity and influence on disease monitoring, prognosis and treatment design
- (2014) Rolf Wouters et al. Expert Review of Hematology
- Distribution and levels of cell surface expression of CD33 and CD123 in acute myeloid leukemia
- (2014) A Ehninger et al. Blood Cancer Journal
- A Niche-Like Culture System Allowing the Maintenance of Primary Human Acute Myeloid Leukemia-Initiating Cells: A New Tool to Decipher Their Chemoresistance and Self-Renewal Mechanisms
- (2014) Emmanuel Griessinger et al. Stem Cells Translational Medicine
- Prospective evaluation of gene mutations and minimal residual disease in patients with core binding factor acute myeloid leukemia
- (2013) E. Jourdan et al. BLOOD
- Overproduction of NOX-derived ROS in AML promotes proliferation and is associated with defective oxidative stress signaling
- (2013) P. S. Hole et al. BLOOD
- A Pan-BCL2 Inhibitor Renders Bone-Marrow-Resident Human Leukemia Stem Cells Sensitive to Tyrosine Kinase Inhibition
- (2013) Daniel J. Goff et al. Cell Stem Cell
- BCL-2 Inhibition Targets Oxidative Phosphorylation and Selectively Eradicates Quiescent Human Leukemia Stem Cells
- (2013) Eleni D. Lagadinou et al. Cell Stem Cell
- Predicting effects of kinase inhibitor in therapy for myeloid malignancies – the challenges in capturing disease heterogeneity
- (2013) Håkon Reikvam et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Role of DNMT3A, TET2, and IDH1/2 mutations in pre-leukemic stem cells in acute myeloid leukemia
- (2013) Steven M. Chan et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Targeting Aberrant Glutathione Metabolism to Eradicate Human Acute Myelogenous Leukemia Cells
- (2013) Shanshan Pei et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Prognostic Relevance of Treatment Response Measured by Flow Cytometric Residual Disease Detection in Older Patients With Acute Myeloid Leukemia
- (2013) Sylvie D. Freeman et al. JOURNAL OF CLINICAL ONCOLOGY
- High Prognostic Impact of Flow Cytometric Minimal Residual Disease Detection in Acute Myeloid Leukemia: Data From the HOVON/SAKK AML 42A Study
- (2013) Monique Terwijn et al. JOURNAL OF CLINICAL ONCOLOGY
- Rapid Diagnosis and Prognosis of de novo Acute Myeloid Leukemia by Serum Metabonomic Analysis
- (2013) Yihuang Wang et al. JOURNAL OF PROTEOME RESEARCH
- JAKs and STATs in Immunity, Immunodeficiency, and Cancer
- (2013) John J. O'Shea et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
- (2013) NEW ENGLAND JOURNAL OF MEDICINE
- Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
- (2013) Francesco Lo-Coco et al. NEW ENGLAND JOURNAL OF MEDICINE
- Role of CXCR4 in the Pathogenesis of Acute Myeloid Leukemia
- (2013) Amnon Peled et al. Theranostics
- The combination of valproic acid, all-trans retinoic acid and low-dose cytarabine as disease-stabilizing treatment in acute myeloid leukemia
- (2013) Hanne Fredly et al. Clinical Epigenetics
- Phase 2 study of the JAK kinase inhibitor ruxolitinib in patients with refractory leukemias, including postmyeloproliferative neoplasm acute myeloid leukemia
- (2012) A. Eghtedar et al. BLOOD
- Minimal residual disease monitoring by quantitative RT-PCR in core binding factor AML allows risk stratification and predicts relapse: results of the United Kingdom MRC AML-15 trial
- (2012) J. A. L. Yin et al. BLOOD
- The Role of JAK Pathway Dysregulation in the Pathogenesis and Treatment of Acute Myeloid Leukemia
- (2012) H. J. Lee et al. CLINICAL CANCER RESEARCH
- The epigenome of AML stem and progenitor cells
- (2012) Jumpei Yamazaki et al. Epigenetics
- Soluble mediators released by acute myeloid leukemia cells increase capillary-like networks
- (2012) Kimberley J. Hatfield et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Bortezomib Added to Daunorubicin and Cytarabine During Induction Therapy and to Intermediate-Dose Cytarabine for Consolidation in Patients With Previously Untreated Acute Myeloid Leukemia Age 60 to 75 Years: CALGB (Alliance) Study 10502
- (2012) Eyal C. Attar et al. JOURNAL OF CLINICAL ONCOLOGY
- A role for GPx3 in activity of normal and leukemia stem cells
- (2012) Olivier Herault et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Local hematopoietic renin-angiotensin system in myeloid versus lymphoid hematological neoplastic disorders
- (2012) Burak Uz et al. JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
- Azacitidine fails to eradicate leukemic stem/progenitor cell populations in patients with acute myeloid leukemia and myelodysplasia
- (2012) C Craddock et al. LEUKEMIA
- Phase IB study of the FLT3 kinase inhibitor midostaurin with chemotherapy in younger newly diagnosed adult patients with acute myeloid leukemia
- (2012) R M Stone et al. LEUKEMIA
- Selective FLT3 inhibition of FLT3-ITD+ acute myeloid leukaemia resulting in secondary D835Y mutation: a model for emerging clinical resistance patterns
- (2012) A S Moore et al. LEUKEMIA
- Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing
- (2012) Li Ding et al. NATURE
- Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemia
- (2012) Tino Schenk et al. NATURE MEDICINE
- Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
- (2012) Jay P. Patel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dependence of Acute Myeloid Leukemia on Adhesion within the Bone Marrow Microenvironment
- (2012) Pamela S. Becker TheScientificWorldJOURNAL
- Inhibition of Mitochondrial Translation as a Therapeutic Strategy for Human Acute Myeloid Leukemia
- (2011) Marko Škrtić et al. CANCER CELL
- Expression of p-JAK2 predicts clinical outcome and is a potential molecular target of acute myelogenous leukemia
- (2011) Takayuki Ikezoe et al. INTERNATIONAL JOURNAL OF CANCER
- Acute Myeloid Leukemia with the t(8;21) Translocation: Clinical Consequences and Biological Implications
- (2011) Håkon Reikvam et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- The bone marrow stem cell niche grows up: mesenchymal stem cells and macrophages move in
- (2011) Armin Ehninger et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Stem cell gene expression programs influence clinical outcome in human leukemia
- (2011) Kolja Eppert et al. NATURE MEDICINE
- Bone marrow aspiration technique may have an impact on therapy stratification in children with acute lymphoblastic leukaemia
- (2011) Jon Helgestad et al. PEDIATRIC BLOOD & CANCER
- Function of leukemogenic mixed lineage leukemia 1 (MLL) fusion proteins through distinct partner protein complexes
- (2011) D. Biswas et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Prospective separation of normal and leukemic stem cells based on differential expression of TIM3, a human acute myeloid leukemia stem cell marker
- (2011) M. Jan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The LKB1/AMPK signaling pathway has tumor suppressor activity in acute myeloid leukemia through the repression of mTOR-dependent oncogenic mRNA translation
- (2010) A. S. Green et al. BLOOD
- Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials
- (2010) D. Grimwade et al. BLOOD
- IDH1 and IDH2: Not Your Typical Oncogenes
- (2010) Zachary J. Reitman et al. CANCER CELL
- The Common Feature of Leukemia-Associated IDH1 and IDH2 Mutations Is a Neomorphic Enzyme Activity Converting α-Ketoglutarate to 2-Hydroxyglutarate
- (2010) Patrick S. Ward et al. CANCER CELL
- DNA Methylation Signatures Identify Biologically Distinct Subtypes in Acute Myeloid Leukemia
- (2010) Maria E. Figueroa et al. CANCER CELL
- Phase IIB Trial of Oral Midostaurin (PKC412), the FMS-Like Tyrosine Kinase 3 Receptor (FLT3) and Multi-Targeted Kinase Inhibitor, in Patients With Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome With Either Wild-Type or Mutated FLT3
- (2010) Thomas Fischer et al. JOURNAL OF CLINICAL ONCOLOGY
- Early assessment of treatment response in patients with AML using [18F]FLT PET imaging
- (2010) Matt Vanderhoek et al. LEUKEMIA RESEARCH
- Monoclonal antibody therapy directed against human acute myeloid leukemia stem cells
- (2010) R Majeti ONCOGENE
- Identification of Therapeutic Targets for Quiescent, Chemotherapy-Resistant Human Leukemia Stem Cells
- (2010) Y. Saito et al. Science Translational Medicine
- CD47 Is an Adverse Prognostic Factor and Therapeutic Antibody Target on Human Acute Myeloid Leukemia Stem Cells
- (2009) Ravindra Majeti et al. CELL
- Monoclonal Antibody-Mediated Targeting of CD123, IL-3 Receptor α Chain, Eliminates Human Acute Myeloid Leukemic Stem Cells
- (2009) Liqing Jin et al. Cell Stem Cell
- Anti-CD38 antibody-mediated clearance of human repopulating cells masks the heterogeneity of leukemia-initiating cells
- (2008) D. C. Taussig et al. BLOOD
- Targeting the leukemia microenvironment by CXCR4 inhibition overcomes resistance to kinase inhibitors and chemotherapy in AML
- (2008) Z. Zeng et al. BLOOD
- Primary human acute myeloid leukaemia cells increase the proliferation of microvascular endothelial cells through the release of soluble mediators
- (2008) Kimberley Hatfield et al. BRITISH JOURNAL OF HAEMATOLOGY
- Improvements in survival of adults diagnosed with acute myeloblastic leukemia in the early 21st century
- (2008) D. Pulte et al. HAEMATOLOGICA
- Induction of apoptosis in leukemic cell lines treated with captopril, trandolapril and losartan: A new role in the treatment of leukaemia for these agents
- (2008) Silvia De la Iglesia Iñigo et al. LEUKEMIA RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started